Barinthus Biotherapeutics: Pioneering T‑Cell Immunotherapy for Cancer and Chronic Diseases
Barinthus Biotherapeutics, a UK‑based clinical‑stage biopharma, pioneers T‑cell immunotherapies targeting cancer, autoimmunity and chronic infections—transforming patient care and investor prospects.
- BARINTHUS BIOTHERAPEUTICS PL
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read